Aster Silicates Ltd IPO

Incorporated in 1996, Aster Silicates Ltd is engaged in the business of manufacturing of sodium silicate which includes food grade sodium silicate, special drilling grade silicate and detergent grade silicate. Aster Silicates produce sodium silicate both in glass and liquid form. Food grade sodium silicate is used in the manufacturing of Silica precipitate and Gel which finds its applications in toothpaste, salt, cosmetics, glucose powder, tyre & rubber and pesticides etc. Sodium silicate, (special drilling grade silicate) is also used in off-shore drilling and for reactivation of old oil and gas fields. The sodium silicate manufactured by Aster is also used in water-proofing, infoundries and for investment casting, paper, silica gel, textiles and detergents.



Currently, Aster operate from two units in Gujarat having aggregate installed capacity of 150 MT of glass/day. Unit I has three furnaces with an average combined capacity of 100 MT of glass/day. Unit II has a single furnace with a capacity of 50 mts of glass/day, which is also triple pass regenerative and recuperative end fired glass furnace.

For the proposed project, Company intends to install a special designed triple pass regenerative and recuperative Furnace of 100 MT capacity each capable of working on biogas with a facility of having duel fuel arrangement for working on other fuel like Natural Gas etc. The furnace shall be capable of being operated both manually and automatically, and shall also possess versatility for manufacturing Sodium Silicate in glass and liquid format. For the expansion of manufacturing facilities at Bharuch, company initially intend to use Natural gas from Gujarat Gas Company Limited as a source of fuel. However, gradually, they intend to shift the fuel source to Biogas, and have Natural gas as a standby arrangement.

Objects of the Issue:

The object of the issue are:
1. Expansion of Manufacturing facilities;
2. Additional Working Capital Requirements;
3. Public Issue expenses.

Issue Detail:
»» Issue Open: Jun 24, 2010 - Jun 28, 2010
»» Issue Type: 100% Book Built Issue IPO
»» Issue Size: Equity Shares of Rs. 10
»» Issue Size: Rs. 53.10 Crore
»» Face Value: Rs. 10 Per Equity Share
»» Issue Price: Rs. 112 - Rs. 118 Per Equity Share
»» Market Lot: 50 Shares
»» Minimum Order Quantity: 50 Shares
»» Listing At: BSE, NSE

Parabolic Drugs Limited IPO

Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.


Companies product portfolio comprises 42 APIs and 7 API intermediates which are marketed domestically and exported.

Company own and operate two manufacturing facilities at Derabassi, Punjab, and Panchkula, Haryana. Company is in the process of setting up a custom synthesis and research and development (R&D) center at Barwala, Haryana.

Company Promoters:
The Promoters of our Company are:

1. Mr. Pranav Gupta;
2. Mr. Vineet Gupta;
3. PNG Trading Private Limited; and
4. Parabolic Infrastructure Private Limited

Objects of the Issue:

The objects of the issue are:
1. Multi-purpose block III at Derabassi;
2. Sterile Cephalosporin Plant (Derabassi);
3. Establishment of Chachrauli Plant;
4. Custom Synthesis & Manu. Site II at IT Park (Panchkula);
5. Repayment / Prepayment of identified loan facility;
6. General corporate purposes.

Issue Detail:
»» Issue Open: Jun 14, 2010 - Jun 17, 2010
»» Issue Type: 100% Book Built Issue IPO
»» Issue Size: 26,666,667 Equity Shares of Rs. 10
»» Issue Size: Rs. 200.00 Crore
»» Face Value: Rs. 10 Per Equity Share
»» Issue Price: Rs. 75 - Rs. 85 Per Equity Share
»» Market Lot: 80 Shares
»» Minimum Order Quantity: 80 Shares
»» Listing At: BSE, NSE